IP Library Patent Application 18253484
Patent Application
App. No. 18/253,484

Yeast B-Glucan Emulsion, Methods and Uses Thereof

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/253,484
Abstract

The present disclosure relates to a yeast β-Glucan emulsion for use in prevention or treatment of herpes simplex virus infection, in particular wherein the emulsion comprises an emollient agent, wherein the emollient agent is selected from: squalane, butter, hemp oil, or mixtures thereof. The present disclosure relates to yeast β-Glucan emulsion with anti-herpetic activity, in particular a face topical composition, more in particular lipstick/face stick/lip or face balm/roll on with anti-herpetic properties; method for obtaining and their use thereof. The present disclosure also relates to a face topical composition, preferably antiherpetically active lipstick, or face stick, or an antiherpetic lip or face balm, or an antiherpetic roll on comprising β-glucans and the use for the prevention and treatment of disorders of the lips and other areas of the face caused by human herpes viruses.

Claims (26)

1 . A yeast β-Glucan emulsion, comprising:

30-80% w/w of an emollient agent;

wherein the yeast β-Glucan emulsion is an antiviral agent;

wherein the yeast β-Glucan amount ranges from 4-25% w/w; and

wherein the yeast β-Glucan emulsion exhibits anti-herpetic properties for preventing or treating a herpes simplex virus infection.

2 . The yeast β-Glucan emulsion of claim 1 , wherein the emollient agent is selected from the group consisting of: squalane, butter, hemp oil, and mixtures thereof.

3 . The yeast β-Glucan emulsion of claim 2 , wherein the β-Glucan emulsion is formulated for the prevention and treatment of labial diseases or other areas of the face or of the lip affected by human herpes viruses.

4 . The yeast β-Glucan emulsion of claim 1 , wherein the β-Glucan emulsion is in the form of a face topical composition.

5 . The yeast β-Glucan emulsion of claim 1 , wherein the yeast β-Glucan emulsion is insoluble in water.

6 . The yeast β-Glucan emulsion of claim 1 , wherein the yeast β-glucan amount ranges from 4-10% w/w.

7 . The yeast β-Glucan emulsion of claim 1 , wherein the yeast β-glucan amount ranges from 4-7% w/w.

8 . The yeast β-Glucan emulsion of claim 1 , wherein the yeast β-glucan amount ranges from 4-6% w/w.

9 . The yeast β-Glucan emulsion of claim 1 , wherein the molecular weight of the yeast β-Glucan ranges from 200-800 KDa.

10 . The yeast β-Glucan emulsion of claim 1 , wherein the molecular weight of the yeast β-Glucan ranges from 300-600 KDa.

11 . The yeast β-Glucan emulsion of claim 1 , wherein the emollient agent amount ranges from 60-80% w/w.

12 . A facial topical composition comprising a yeast β-Glucan emulsion wherein the emulsion comprises an emollient agent, wherein the composition is formulated for the prevention or treatment of a herpes simplex virus infection via topical administration to the face of a subject, and wherein said composition is in the form of an antiherpetic lipstick, face stick, lip or face balm, or a roll on.

13 . The topical composition of claim 12 , wherein the emollient agent is selected from the group consisting of: squalane, butter, hemp oil, or and mixtures thereof.

14 . The topical composition of claim 12 , wherein the topical composition further comprises at least one of the following compounds: a filler, an oil, a preservative, a dye, an aroma, a flavour, a hydrating agent, a pH adjuster, a stabilizer, a thickener, or combinations thereof.

15 . The topical composition of claim 14 , wherein the filler is selected from group consisting of: waxes, paraffin, beeswax, and mixtures thereof; and wherein the preservative is selected from the group consisting of: citric acid, phenethyl alcohol, benzoic acid, sorbic acid, salicylic acid alcohol, tocopherol, and mixtures thereof.

16 . The topical composition of claim 15 , wherein:

the filler amount ranges from 10-30% w/v; and the preservative amount ranges from 0.1-2% w/w.

17 . The topical composition of claim 12 , wherein the weight ratio of β-glucan/emollient agent ranges from 0.5:1-1:2.

18 . A method of obtaining a yeast β-Glucan comprising:

obtaining autolyzed yeasts cells;

extract dried alkali-glucans of the yeast by adding an alkaline solution to the yeast cells in a solid-liquid extraction and collecting a first pellet; and

adding to the obtained first pellet an alcoholic solution and an acid solution in a second solid-liquid extraction to obtain a second pellet with yeast β-Glucan.

Assignments (3)
SECURITY INTEREST Recorded Aug 17, 2023
From: AMYRIS, INC.; AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; APRINNOVA, LLC; AMYRIS-OLINKA, LLC; ONDA BEAUTY INC.; UPLAND 1 LLC; AMYRIS ECO-FAB LLC; CLEAN BEAUTY 4U HOLDINGS, LLC; AMYRIS CLEAN BEAUTY LATAM LTDA; INTERFACES INDUSTRIA E COMERCIA DE COSMETICOS LTDA; AMYRIS BIOTECHNOLOGIA DO BRASIL LTDA; AMYRIS EUROPE TRADING B.V. (NETHERLANDS); AMYRIS BIO PRODCUTS PORTUGAL, UNIPESSOAL, LDA; BEAUTY LABS INTERNATIONAL LIMITED; AMYRIS UK TRADING LIMITED
To: EUAGORE, LLC
Reel/Frame 064619/0778 →
SECURITY INTEREST Recorded Aug 3, 2023
From: AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; AMYRIS, INC.
To: MUIRISC, LLC
Reel/Frame 064492/0518 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2023
From: CRUZ FERNANDES, JOÃO; FARIA AMORIM, MARIA MANUELA; CONSTANTE DE SOUSA, PEDRO MIGUEL; TAVARES VALENTE, DIANA MARIA; AZEVEDO SILVA, JOÃO PEDRO; ESTEVEZ PINTADO, MARIA MANUELA
To: UNIVERSIDADE CATÓLICA PORTUGUESA - UCP; AMYRIS BIO PRODUCTS PORTUGAL UNIPESSOAL LDA
Reel/Frame 063684/0720 →